ROSEN LAW FIRM, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Legend Biotech Corporation – LEGN

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Legend Biotech Corporation (NASDAQ: LEGN) resulting from allegations that Legend may have issued materially misleading business information to the investing public.